Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc
(NY:
CYBN
)
0.2680
+0.0007 (+0.26%)
Official Closing Price
Updated: 4:10 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cybin Inc
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Holds Initial Breakthrough Therapy Meeting with FDA, Plans for CYB003 Phase 3 Trial
August 13, 2024
Via
Investor Brand Network
Exposures
Product Safety
Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder
August 13, 2024
From
Cybin Inc.
Via
Business Wire
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
August 09, 2024
CYBN stock results show that Cybin beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases Q1 2025 Financial Results, Business Highlights
August 08, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
CYBN Stock Earnings: Cybin Beats EPS for Q4 2023
June 26, 2024
CYBN stock results show that Cybin beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
August 08, 2024
From
Cybin Inc.
Via
Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO to Participate in a Fireside Chat at Upcoming Conference
August 07, 2024
Via
Investor Brand Network
Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 07, 2024
From
Cybin Inc.
Via
Business Wire
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.
Via
Benzinga
3 Biotech Stocks That Could Make Your Summer Unforgettable
July 30, 2024
If you want to do well with biotech stocks, trade the anticipation of news. Here are three stocks to consider.
Via
InvestorPlace
Cybin Inc. Stands Strong As A Remaining Force To Prove Benefits Of Psychedelic Therapeutics ($CYBN)
July 10, 2024
Via
AB Newswire
Exposures
Product Safety
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Sees “Swell” of Insider Investments, Upgrade in Ranking after Positive Year-End Report
July 08, 2024
Via
Investor Brand Network
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
July 03, 2024
Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks.
Via
InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
July 02, 2024
These are three of the best psychedelic stocks to buy on the dip for potentially lucrative future growth and returns.
Via
InvestorPlace
Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development
June 26, 2024
Explore Cybin Inc.'s FY 2024 results: $78M loss and strides in psychedelic therapy for mental health. Read now!
Via
Benzinga
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
June 26, 2024
From
Cybin Inc.
Via
Business Wire
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO Featured Presenter at Upcoming H.C. Wainwright Neuro Perspectives Virtual Conference
June 20, 2024
Via
Investor Brand Network
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Releases FY Financial Report, Business Update
June 26, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 19, 2024
From
Cybin Inc.
Via
Business Wire
Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More
June 18, 2024
As the premier gathering of top entrepreneurs and investors is taking place this Monday in New Jersey, let's scroll through the latest leadership changes in the cannabis and psychedelics...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Strategic Appointment of Dr. Atul Mahableshwarkar
June 11, 2024
Via
Investor Brand Network
Exposures
Product Safety
Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development
June 11, 2024
From
Cybin Inc.
Via
Business Wire
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
June 05, 2024
FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.
Via
Benzinga
Exposures
Product Safety
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at Interdisciplinary Conference on Psychedelic Research 2024
May 29, 2024
Via
Investor Brand Network
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
May 29, 2024
From
Cybin Inc.
Via
Business Wire
BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) CEO Slated to Present at Upcoming Alliance Global Partners Healthcare Company Showcase
May 14, 2024
Via
Investor Brand Network
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
May 14, 2024
From
Cybin Inc.
Via
Business Wire
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
May 09, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Issues Corporate Update, Eyes Runway for Upcoming Clinical Milestones
May 06, 2024
Via
Investor Brand Network
Exposures
Product Safety
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
May 06, 2024
From
Cybin Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.